Auto-immune neutropenia associated with metformin in a patient with splenic marginal zone lymphoma

Pharmacy World and Science

Volumn 30, Issue 4, 2008, Pages 319-321

  Laporte, Franck ^a   Hamdi, Safouane ^a   Oksman, Françoise ^b   Huguet, Françoise ^a  

^a CHU PURPAN   (France)

^b CHU RANGUEIL   (France)

Author keywords

Auto immune neutropenia; Fludarabine; Metformin; Splenic marginal zone lymphoma

Indexed keywords

ACEBUTOLOL; CLOPIDOGREL; ENALAPRIL; FLUDARABINE; GRANULOCYTE ANTIBODY; METFORMIN; MOLSIDOMINE; WARFARIN;

AGED; ANGINA PECTORIS; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; DIABETES MELLITUS; DIET RESTRICTION; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; GERIATRIC PATIENT; HUMAN; LEUKOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOMA; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; SPLEEN TUMOR; SPLENIC MARGINAL ZONE LYMPHOMA; T LYMPHOCYTE; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS; AUTOIMMUNE DISEASES; GRANULOCYTES; HUMANS; HYPOGLYCEMIC AGENTS; LEUKOCYTE COUNT; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; METFORMIN; NEUTROPENIA; SPLENIC NEOPLASMS; VIDARABINE;

EID: 46149102467     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-008-9218-3     Document Type: Article

References (11)

1. Lin KD, Lin JD, Juang JH. Metformin-induced hemolysis with jaundice. N Engl J Med. 1998;339:1860-1.
2. Kashyap AS, Kashyap S. Haemolytic anaemia due to metformin. Postgrad Med J. 2000;76:125-6.
3. Meyer O, Gaedicke G, Salama A. Demonstration of drug-dependent antibodies in two patients with neutrophenia and successful treatment with granulocyte-colony-stimulating factor. Transfusion. 1999;39:527-30.
4. Thieblemont C, Felman P, Callet-Bauchu E, Traverse-Glehen A, Salles G, Berger F et al. Splenic marginal-zone lymphoma: a distinct clinical and pathological entity. Lancet Oncol. 2003;4:95-103.
5. Dieter RS. Risk of neutropenia with clopidogrel. J Am Coll Cardiol. 2000;36:1436-7.
6. Parish RC, Miller LJ. Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update. Drug Saf. 1992;7:14-31.
7. Stern SC, Shah S, Costello C. Probable autoimmune neutropenia induced by fludarabine treatment for chronic lymphocytic leukaemia. Br J Haematol. 1999;106:836-7.
8. Houben MH, Hoorntje SJ. Pancytopenia due to paludrine (proguanil hydrochloride). Nephron. 1995;71:368.
9. Humphrey CA, French A, Morris TC. Prospective in vitro testing for drug-induced neutropenia in a patient requiring anti-malarial prophylaxis: confirmation of findings on exposure of patient to drug. Clin Lab Haematol. 1990;12:31-6.
10. Gamberale R, Galmarini CM, Fernandez-Calotti P, Jordheim L, Sanchez-Avalos J, Dumontet C, et al. In vitro susceptibility of CD4+ and CD8+ T cell subsets to fludarabine. Biochem Pharmacol. 2003;66:2185-91.
11. Van Den Neste E, Delannoy A, Feremans W, Ferrant A, Michaux L. Second primary tumors and immune phenomena after fludarabine or 2-chloro-2′- deoxyadenosine treatment. Leuk Lymphoma. 2001;40:541-50.